Total Payments
$597.33
2018 Payments
$324.75
Companies
14
Transactions
25
Medicare Patients
1,287
Medicare Billing
$121,463
Payment Breakdown by Category
Food & Beverage$597.33 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $597.33 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cook Medical LLC | $138.79 | 2 | $0 (2018) |
| Gilead Sciences Inc | $124.80 | 1 | $0 (2017) |
| Ferring Pharmaceuticals Inc. | $80.87 | 5 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $50.57 | 3 | $0 (2018) |
| Allergan Inc. | $33.12 | 2 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $31.33 | 2 | $0 (2018) |
| Janssen Biotech, Inc. | $26.61 | 2 | $0 (2018) |
| Synergy Pharmaceuticals Inc | $25.41 | 2 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $21.71 | 1 | $0 (2017) |
| HOSPIRA, INC. | $17.17 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $324.75 | 14 | Cook Medical LLC ($138.79) |
| 2017 | $272.58 | 11 | Gilead Sciences Inc ($124.80) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2018 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Immunology | ||||||
| 11/14/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Lower GI | ||||||
| 10/19/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Lower GI | ||||||
| 10/16/2018 | Cook Medical LLC | COOK MEDICAL BILIARY (Device) | Food and Beverage | Cash or cash equivalent | $134.38 | General |
| Category: Endoscopy | ||||||
| 10/15/2018 | Cook Medical LLC | COOK MEDICAL BILIARY (Device) | Food and Beverage | Cash or cash equivalent | $4.41 | General |
| Category: Endoscopy | ||||||
| 10/12/2018 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: Immunology | ||||||
| 10/09/2018 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: Immunology | ||||||
| 06/27/2018 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/05/2018 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/20/2018 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/09/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | APRISO (Drug), UCERIS | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/05/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Lower GI | ||||||
| 01/03/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/28/2017 | Braintree Laboratories, Inc. | SUPREP (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/20/2017 | Ferring Pharmaceuticals Inc. | PREPOPIK (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/20/2017 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Gastroenterology | ||||||
| 08/28/2017 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Gastroenterology | ||||||
| 07/13/2017 | HOSPIRA, INC. | INFLECTRA (Biological) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: INFLAMMATION | ||||||
| 06/20/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/18/2017 | Ferring Pharmaceuticals Inc. | PREPOPIK (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/08/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/03/2017 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: Anemia | ||||||
| 02/16/2017 | Gilead Sciences Inc | Epclusa (Drug) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: HCV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 332 | 383 | $551,290 | $30,952 |
| 2022 | 11 | 330 | 370 | $518,752 | $29,980 |
| 2021 | 10 | 331 | 380 | $463,675 | $32,507 |
| 2020 | 7 | 294 | 378 | $361,340 | $28,023 |
Total Patients
1,287
Total Services
1,511
Medicare Billing
$121,463
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 65 | 97 | $35,890 | $5,323 | 14.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 25 | 25 | $108,750 | $4,489 | 4.1% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 65 | 69 | $30,015 | $3,754 | 12.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $24,480 | $3,666 | 15.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 30 | 30 | $104,400 | $3,305 | 3.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 49 | 55 | $145,750 | $3,170 | 2.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 14 | 14 | $41,020 | $2,347 | 5.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 27 | $13,230 | $2,062 | 15.6% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 14 | 21 | $42,420 | $1,920 | 4.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $5,335 | $916.30 | 17.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 68 | 95 | $33,725 | $4,823 | 14.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 28 | 28 | $117,040 | $4,548 | 3.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 36 | 36 | $24,732 | $3,612 | 14.6% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 46 | 50 | $20,750 | $3,569 | 17.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 53 | 55 | $139,700 | $3,549 | 2.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 25 | 25 | $83,750 | $3,000 | 3.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $41,860 | $1,747 | 4.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 22 | $10,230 | $1,685 | 16.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 15 | $9,870 | $1,499 | 15.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $32,400 | $1,051 | 3.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 12 | 15 | $4,695 | $898.48 | 19.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 80 | 108 | $35,640 | $5,844 | 16.4% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 21 | 24 | $96,515 | $4,481 | 4.6% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 52 | 56 | $134,960 | $4,059 | 3.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 33 | 33 | $21,285 | $3,974 | 18.7% |
About Dr. Sotirios Vasilopoulos, M.D
Dr. Sotirios Vasilopoulos, M.D is a Gastroenterology healthcare provider based in Cudahy, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568432912.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sotirios Vasilopoulos, M.D has received a total of $597.33 in payments from pharmaceutical and medical device companies, with $324.75 received in 2018. These payments were reported across 25 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($597.33).
As a Medicare-enrolled provider, Vasilopoulos has provided services to 1,287 Medicare beneficiaries, totaling 1,511 services with total Medicare billing of $121,463. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Cudahy, WI
- Active Since 01/26/2006
- Last Updated 06/11/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1568432912
Products in Payments
- COOK MEDICAL BILIARY (Device) $138.79
- Epclusa (Drug) $124.80
- CLENPIQ (Drug) $52.31
- Entyvio (Biological) $50.57
- XIFAXAN (Drug) $38.72
- LINZESS (Drug) $33.12
- PREPOPIK (Drug) $28.56
- REMICADE (Biological) $26.61
- Trulance (Drug) $25.41
- INFLECTRA (Biological) $17.17
- SUPREP (Drug) $14.51
- APRISO (Drug) $14.32
- INJECTAFER (Drug) $11.02
- Cimzia (Drug) $10.71
- DIFICID (Drug) $10.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.